DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 123 filers reported holding DERMIRA INC in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $981,000 | -15.8% | 106,593 | -26.9% | 0.10% | -29.0% |
| Q1 2018 | $1,165,000 | +100.9% | 145,785 | +632.0% | 0.14% | +85.9% |
| Q2 2017 | $580,000 | -6.5% | 19,917 | +9.6% | 0.08% | -31.0% |
| Q1 2017 | $620,000 | -3.3% | 18,180 | -14.0% | 0.11% | -29.4% |
| Q4 2016 | $641,000 | -3.5% | 21,129 | +7.6% | 0.16% | +90.5% |
| Q3 2016 | $664,000 | – | 19,641 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
| NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
| GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
| APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
| NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
| Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
| Jeneq Management LP | 96,570 | $923,000 | 0.82% |
| Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
| PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
| Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |